Procter & Gamble Company (NYSE: PG) details Health Care CEO retirement

Rhea-AI Filing Summary

The Procter & Gamble Company disclosed that Jennifer Davis, currently Chief Executive Officer - Health Care, has notified the company of her intent to retire. The notice was given on December 9, 2025, and her retirement is expected to be effective June 30, 2026.

Davis is retiring after more than 33 years of service with Procter & Gamble, reflecting a long tenure in senior leadership. The filing does not provide additional details on succession or changes to the company’s broader strategy.

0000080424FalseFalse00000804242025-12-152025-12-150000080424us-gaap:CommonStockMember2025-12-152025-12-150000080424exch:XNYS2025-12-152025-12-150000080424pg:A0.110NotesDue2026Domain2025-12-152025-12-150000080424pg:A3.25EURNotesDue2026Domain2025-12-152025-12-150000080424pg:A4.875EURNotesDueMay2027Domain2025-12-152025-12-150000080424pg:A1.200NotesDue2028Domain2025-12-152025-12-150000080424pg:A3.150EURNotesDue2028Domain2025-12-152025-12-150000080424pg:A1.250NotesDue2029Domain2025-12-152025-12-150000080424pg:A1.800NotesDue2029Domain2025-12-152025-12-150000080424pg:A6.250GBPNotesDueJanuary2030Domain2025-12-152025-12-150000080424pg:A0.350NotesDue2030Domain2025-12-152025-12-150000080424pg:A0.230NotesDue2031Domain2025-12-152025-12-150000080424pg:A3.250EURNotesDue2031Domain2025-12-152025-12-150000080424pg:A5.250GBPNotesDueJanuary2033Domain2025-12-152025-12-150000080424pg:A2.900EURNotesDue2033Domain2025-12-152025-12-150000080424pg:A3.200EURNotesDue2034Domain2025-12-152025-12-150000080424pg:A1.875NotesDue2038Domain2025-12-152025-12-150000080424pg:A0.900NotesDue2041Domain2025-12-152025-12-150000080424pg:A3.650EURNotesDue2045Domain2025-12-152025-12-15

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

___________________________________

FORM 8-K

___________________________________

CURRENT REPORT

Pursuant to Section 13 or 15(d)

of the Securities Exchange Act of 1934

Date of Report (date of earliest event reported): December 15, 2025 (December 9, 2025)

___________________________________

The Procter & Gamble Company

(Exact name of registrant as specified in its charter)

___________________________________

Ohio (State or other jurisdiction of incorporation or organization)			001-00434 (Commission File Number)			31-0411980 (I.R.S. Employer Identification Number)
One Procter & Gamble Plaza Cincinnati, Ohio 45202
(Address of principal executive offices and zip code)
(513) 983-1100
(Registrant's telephone number, including area code)

___________________________________

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐			Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐			Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐			Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐			Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:
Title of each class			Trading Symbol			Name of each exchange on which registered
Common Stock without Par Value			PG			NYSE
0.110% Notes due 2026			PG26D			NYSE
3.25% EUR Notes due 2026			PG26F			NYSE
4.875% EUR Notes due May 2027			PG27A			NYSE
1.200% Notes due 2028			PG28			NYSE
3.150% EUR Notes due 2028			PG28B			NYSE
1.250% Notes due 2029			PG29B			NYSE
1.800% Notes due 2029			PG29A			NYSE
6.250% GBP Notes due January 2030			PG30			NYSE
0.350% Notes due 2030			PG30C			NYSE
0.230% Notes due 2031			PG31A			NYSE
3.250% EUR Notes due 2031			PG31B			NYSE
5.250% GBP Notes due January 2033			PG33			NYSE
2.900% EUR Notes due 2033			PG33B			NYSE
3.200% EUR Notes due 2034			PG34C			NYSE
1.875% Notes due 2038			PG38			NYSE
0.900% Notes due 2041			PG41			NYSE
3.650% Notes due 2045			PG45			NYSE

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 12b-2 of the Exchange Act.

Emerging growth company    ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.

ITEM 5.02 DEPARTURE OF DIRECTORS OR CERTAIN OFFICERS; ELECTION OF DIRECTORS; APPOINTMENT OF CERTAIN OFFICERS; COMPENSATORY ARRANGEMENTS OF CERTAIN OFFICERS.

On December 9, 2025, Jennifer Davis, currently Chief Executive Officer - Health Care, notified the Company of her intent to retire effective June 30, 2026, after more than 33 years of service.

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized on this 15th day of December, 2025.

THE PROCTER & GAMBLE COMPANY
By:			/s/ Sandra T. Lane
Name:			Sandra T. Lane
Title:			Assistant Secretary

FAQ

What executive change did Procter & Gamble (PG) report in this filing?

Procter & Gamble reported that Jennifer Davis, its Chief Executive Officer - Health Care, has notified the company of her intent to retire.

When will Jennifer Davis retire from Procter & Gamble (PG)?

Jennifer Davis is expected to retire from Procter & Gamble effective June 30, 2026.

What is Jennifer Davis’s current role at Procter & Gamble (PG)?

Jennifer Davis currently serves as Chief Executive Officer - Health Care at Procter & Gamble.

How long has Jennifer Davis been with Procter & Gamble (PG)?

Jennifer Davis is retiring after more than 33 years of service with Procter & Gamble.

On what date did Jennifer Davis notify Procter & Gamble of her retirement plans?

Jennifer Davis notified Procter & Gamble of her retirement plans on December 9, 2025.

Does the Procter & Gamble (PG) filing name a successor for Jennifer Davis?

The filing does not name a successor or describe further leadership changes related to Jennifer Davis’s retirement.